ICF syndrome is a rare autosomal recessive immunoglobulin deficiency, somet
imes combined with defective cellular immunity. Other features that are fre
quently observed in ICF syndrome patients include facial dysmorphism, devel
opmental delay, and recurrent infections. The most diagnostic feature of IC
F syndrome is the branching of chromosomes 1, 9, and 16 due to pericentrome
ric instability. Positional candidate cloning recently discovered the de no
vo DNA methyltransferase: 3B (DNMT3B) as the responsible gene by identifyin
g seven different mutations in nine ICF patients. DNMT3B specifically methy
lates repeat sequences adjacent to the centromeres of chromosome 1, 9, and
16. Our panel of 14 ICF patients was subjected to mutation analysis in the
DNMT3B gene. Mutations in DNMT3B were discovered in only nine of our 14 ICF
patients. Moreover, two ICF patients from consanguineous families who did
not show autozygosity (i.e. homozygosity by descent) for the DNMT3B locus d
id not reveal DNMT3B mutations, suggesting genetic heterogeneity for this d
isease. Mutation analysis revealed 11 different mutations, including seven
novel ones: eight different missense mutations, two different nonsense muta
tions, and a splice-site mutation leading to the insertion of three aa's. T
he missense mutations occurred in or near the catalytic domain of DNMT3B pr
otein, indicating a possible interference with the normal functioning of th
e enzyme. However, none of the ICF patients was homozygous for a nonsense a
llele, suggesting that absence of this enzyme is not compatible with life.
Compound heterozygosity for a missense and a nonsense mutation did not seem
to correlate with a more severe phenotype. Hum Mutat 16:509-517, 2000. (C)
2000 Wiley Liss, Inc.